Sysmex and Mongolia’s Ministry of Health and Sports working together to enhance the quality of testing for infectious diseases in immunochemistry.
Celebrating its 60th year, Sysmex was proud to be involved with the RCPA annual conference and exhibition held in Melbourne last weekend. The conference is multidisciplinary covering all aspects of pathology and laboratory medicine and attracted over 1200 delegates. As it is an Australasian event, Sysmex staff from both sides of the Tasman attended the […]
The Tokyo-based Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering today announced three recipients of The Nakatani Award, 30 recipients of
its Technology Development Research Grants and three recipients of its Investigative Research Grants for fiscal 2015.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) is launching a new product in the sediment urinalysis testing field, the UD-10 fully-automated imaging unit, for formed elements in urine.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has been selected as one of the 2016 Global 100’s Most Sustainable Companies in the World, a ranking conducted by Canadian publisher Corporate Knights.
Medicaroid Corporation (HQ: Kobe, Japan; President: Yasuhiko Hashimoto; hereinafter, “Medicaroid”), a joint venture between Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu; hereinafter, “Sysmex”) and Kawasaki Heavy Industries, Ltd. (HQ: Kobe, Japan; President: Shigeru Murayama; hereinafter, “Kawasaki”), has established a subsidiary in the United States, MEDICAROID, INC., which commenced operations in January 2016. MEDICAROID, INC. will cooperate with Medicaroid to conduct medical robot technology development, marketing activities and regulatory affairs for approval by the US Food and Drug Administration (FDA), with the aim of expanding business going forward.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Ghana. Going forward, the Company aims to reinforce distributor support and expand its business in the markets of West and Central Africa.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and the National Cancer Center (Location: Tokyo, Japan; President: Tomomitsu Hotta) have opened a joint research laboratory within the National Cancer Center Hospital (Location: Tokyo, Japan; Director: Yasuaki Arai) to promote joint development in the field of cancer diagnosis.
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) have been selected by the Japan Investor Relations Association (JIRA) to receive its 20th “IR Grand Prix Award.” This is the first time Sysmex has won the IR Grand Prix Award, for which companies become eligible after they have won the Best IR Award twice in the past. Past award successes for Sysmex include 2004 (IR Award for Small to Medium Capitalization Companies), 2006 (Best IR Award) and 2011 (Best IR Award).
Bay of Plenty DHB has introduced an information-sharing system, BOP MEDCheck, utilising Eclair, to provide community pharmacists access to patients’ records and hospital clinician access to community dispensing information. Article reproduced courtesy of Pharmacy Today.